Dosimetry evaluation and uncertainty analysis of Cobalt-60 HDR brachytherapy for cervical cancer in resource-limited settings
Cobalt-60 HDR brachytherapy provides clinically acceptable dose coverage and OAR sparing, with dosimetric outcomes comparable to Ir-192. Its longer half-life offers practical advantages for LMICs. Optimization of dose distribution and further validation through Monte Carlo simulations and prospective clinical studies are recommended.
Authors
- Ayat M. Saadeldin (ORCID: https://orcid.org/0000-0002-5940-0565)
- I. H. Ibrahim (ORCID: https://orcid.org/0000-0003-0799-3634)
- S. El-Sayed
- Ehab Marouf Attalla
- Asmaa M El-Doushy
Institutions
- Ain Shams University (EG)
- Cairo University (EG)
- Al-Azhar University (EG)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1007/s00432-025-06280-0
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00